We are live on ! Find out more
EDIT icon

Editas Medicine

215 hedge funds and large institutions have $1.15B invested in Editas Medicine in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 56 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 25

49% more call options, than puts

Call options by funds: $40.4M | Put options by funds: $27.1M

30% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 56

11% more capital invested

Capital invested by funds: $1.03B → $1.15B (+$119M)

9% more funds holding

Funds holding: 197215 (+18)

1.62% more ownership

Funds ownership: 66.44%68.05% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
215
Holders Change
+18
Holders Change %
+9.14%
% of All Funds
4.92%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
46
Increased
73
Reduced
56
Closed
25
Calls
$40.4M
Puts
$27.1M
Net Calls
+$13.2M
Net Calls Change
+$651K
Name Holding Trade Value Shares
Change
Change in
Stake
CAG
51
Crestwood Advisors Group
Massachusetts
$2.5M -$7.08K -200 -0.2%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$2.5M +$473K +13,365 +24%
GC
53
Guggenheim Capital
Illinois
$2.4M +$395K +11,154 +20%
AllianceBernstein
54
AllianceBernstein
Tennessee
$2.31M -$711K -20,070 -24%
Korea Investment Corp
55
Korea Investment Corp
South Korea
$2.2M +$2.17M +61,300 New
Swiss National Bank
56
Swiss National Bank
Switzerland
$2.12M +$510K +14,400 +32%
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$1.97M +$333K +9,400 +21%
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$1.94M +$584K +16,500 +44%
Canada Life
59
Canada Life
Manitoba, Canada
$1.9M +$115K +3,249 +7%
MOACM
60
Mutual of America Capital Management
New York
$1.87M +$1.85M +52,135 New
Squarepoint
61
Squarepoint
New York
$1.85M +$916K +25,862 +100%
California Public Employees Retirement System
62
California Public Employees Retirement System
California
$1.81M +$1.79M +50,642 New
JP Morgan Chase
63
JP Morgan Chase
New York
$1.81M -$20.2K -571 -1%
Victory Capital Management
64
Victory Capital Management
Texas
$1.71M -$94.5K -2,670 -5%
CIA
65
Capital Impact Advisors
Massachusetts
$1.7M +$218K +6,170 +15%
State of Wisconsin Investment Board
66
State of Wisconsin Investment Board
Wisconsin
$1.7M +$446K +12,600 +36%
3C
67
361 Capital
Colorado
$1.62M +$1.6M +45,215 New
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$1.57M +$331K +9,343 +27%
Fiera Capital (Canada)
69
Fiera Capital (Canada)
Quebec, Canada
$1.4M -$116K -3,290 -8%
Manulife (Manufacturers Life Insurance)
70
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.22M +$215K +6,077 +22%
Ameriprise
71
Ameriprise
Minnesota
$1.2M +$488K +13,769 +70%
RJA
72
Raymond James & Associates
Florida
$1.16M +$6.09K +172 +0.5%
DekaBank Deutsche Girozentrale
73
DekaBank Deutsche Girozentrale
Germany
$1.15M +$212K +6,000 +23%
CIC
74
Carnegie Investment Counsel
Ohio
$1.09M -$191K -5,400 -13%
MWVC
75
Morgens Waterfall Vintiadis & Co
New York
$1.07M

EDIT Hedge Fund Activity: Q2 2018 in Review

215 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2018, worth a combined $1.15B — up 11% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new EDIT positions and 25 closed out — a net gain of 21 holders — while 73 added to existing stakes and 56 trimmed.

The largest buyer was BlackRock, adding an estimated $20.9M. The largest seller was Fidelity Investments, cutting an estimated $40.7M.

  • 215 institutional investors held Editas Medicine (EDIT) as of Q2 2018, up from 197 in Q1 2018.
  • Funds reported $1.15B of Editas Medicine stock for Q2 2018, up 11% quarter-over-quarter.
  • 46 funds opened new Editas Medicine positions in Q2 2018 and 25 closed out, a net change of +21 holders.
  • The largest Editas Medicine buyer in Q2 2018 was BlackRock, an estimated $20.9M added.
  • The largest Editas Medicine seller in Q2 2018 was Fidelity Investments, an estimated $40.7M sold.

Based on aggregated 13F filings for Q2 2018.